Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
07/18/2017 07/19/2017 07/20/2017 07/21/2017 07/24/2017 Date
3.024(c) 2.94(c) 2.702(c) 2.625(c) 2.7 Last
0 0 0 0 0 Volume
+1.58% -2.78% -8.10% -2.85% +2.86% Change
More quotes
Financials ($)
Sales 2017 107 M
EBIT 2017 -86,6 M
Net income 2017 -89,3 M
Debt 2017 0,50 M
Yield 2017 -
Sales 2018 134 M
EBIT 2018 -69,1 M
Net income 2018 -72,1 M
Finance 2018 0,23 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 3,24x
EV / Sales2018 2,59x
Capitalization 346 M
More Financials
Company
Pacific Biosciences of California, Inc. engages in the research, development and manufacture of sequencing systems for genetic analysis.It operates through the following geographical segments: North America, Europe, and Asia.It offers deoxyribonucleic acid sequencing, third generation sequencing... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
07/18 Novogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Appli..
06/22 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Bis-Biotinylation Tags (US..
06/22 PacBio Technology Resolves Complex Maize Genome, Driving Demand for Other Lar..
06/20 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Entry into a Material Definitive Agreemen..
06/16 PACIFIC BIOSCIENCES OF CALIFORNIA : Announces Pricing of Public Offering of Comm..
06/15 Pacific Biosciences of California, Inc. Announces Pricing of Public Offering ..
06/14 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Other Events, Financial Statements and Ex..
06/14 Pacific Biosciences of California, Inc. Announces Proposed Public Offering of..
06/01 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Arrays of Integrated Analy..
05/25 PACIFIC BIOSCIENCES OF CALIFORNIA, I : PACB) Files An 8-K Submission of Matters ..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
10:43a Autos, airlines hit in sluggish start to European trading week
08:40a ROYAL PHILIPS : Philips targets order book growth of 4-6 percent in 2017 - CEO
07:42aDJROYAL PHILIPS : 2Q Net Profit Rises; Begins EUR1.5 Billion Share Buyback Program
07/20 Abbott profit forecast gets a lift from St. Jude integration
07/18DJROYAL PHILIPS : Philips Buys TomTec Imaging for Undisclosed Sum
More sector news : Advanced Medical Equipment & Technology - NEC
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 6,46 $
Spread / Average Target 103%
EPS Revisions
Managers
NameTitle
Michael W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes CFO, Principal Accounting Officer & Executive VP
Stephen W. Turner Chief Technical Officer & Vice President
James Michael Phillips Senior Vice President-Research & Development
Jonas Korlach Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF CALIFORNIA-28.20%346
THERMO FISHER SCIENTIFIC INC.29.11%71 272
DANAHER6.69%57 694
BOSTON SCIENTIFIC CORPORATION27.69%37 823
INTUITIVE SURGICAL46.25%34 169
ROYAL PHILIPS6.86%33 996